China’s BD111 is The Most Advanced Gene-Editing Therapy Targeting HSV in Humans
Chinese biotech company BDgene Therapeutics, based in Shanghai, has developed BD111, a gene-editing therapy using CRISPR-Cas9 technology to target and remove...
Read More